Chen ZS - Search Results

1

Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic Bacteria.

Kong J, Wu ZX, Wei L, Chen ZS, Yoganathan S. Kong J, et al. Among authors: chen zs. Front Microbiol. 2020 Jul 29;11:1718. doi: 10.3389/fmicb.2020.01718. eCollection 2020. Front Microbiol. 2020. PMID: 32849365 Free PMC article.

2

The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.

Kathawala RJ, Wei L, Anreddy N, Chen K, Patel A, Alqahtani S, Zhang YK, Wang YJ, Sodani K, Kaddoumi A, Ashby CR Jr, Chen ZS. Kathawala RJ, et al. Among authors: chen k, chen zs. Oncotarget. 2015 Jan 1;6(1):510-21. doi: 10.18632/oncotarget.2638. Oncotarget. 2015. PMID: 25402202 Free PMC article.

3

Silver nanoparticles: synthesis, properties, and therapeutic applications.

Wei L, Lu J, Xu H, Patel A, Chen ZS, Chen G. Wei L, et al. Among authors: chen zs, chen g. Drug Discov Today. 2015 May;20(5):595-601. doi: 10.1016/j.drudis.2014.11.014. Epub 2014 Dec 24. Drug Discov Today. 2015. PMID: 25543008 Free PMC article. Review.

4

PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

Gupta P, Kathawala RJ, Wei L, Wang F, Wang X, Druker BJ, Fu LW, Chen ZS. Gupta P, et al. Among authors: chen zs. Cancer Lett. 2016 Dec 28;383(2):220-229. doi: 10.1016/j.canlet.2016.09.025. Epub 2016 Oct 5. Cancer Lett. 2016. PMID: 27720778

5

Modulating ROS to overcome multidrug resistance in cancer.

Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR Jr, Yang DH, Chen ZS. Cui Q, et al. Among authors: chen zs. Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14. Drug Resist Updat. 2018. PMID: 30471641 Review.

6

Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates.

Gupta P, Gao HL, Ashar YV, Karadkhelkar NM, Yoganathan S, Chen ZS. Gupta P, et al. Among authors: chen zs. Int J Mol Sci. 2019 Jan 11;20(2):268. doi: 10.3390/ijms20020268. Int J Mol Sci. 2019. PMID: 30641875 Free PMC article.

7

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.

Wu ZX, Teng QX, Cai CY, Wang JQ, Lei ZN, Yang Y, Fan YF, Zhang JY, Li J, Chen ZS. Wu ZX, et al. Among authors: chen zs. Biochem Pharmacol. 2019 Aug;166:120-127. doi: 10.1016/j.bcp.2019.05.015. Epub 2019 May 9. Biochem Pharmacol. 2019. PMID: 31078601

8

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.

Ji N, Yang Y, Cai CY, Wang JQ, Lei ZN, Wu ZX, Cui Q, Yang DH, Chen ZS, Kong D. Ji N, et al. Among authors: chen zs. Front Oncol. 2019 Jun 18;9:514. doi: 10.3389/fonc.2019.00514. eCollection 2019. Front Oncol. 2019. PMID: 31275850 Free PMC article.

9

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.

Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, Huang JJ, Ashby CR Jr, Chen ZS. Narayanan S, et al. Among authors: chen zs. Drug Resist Updat. 2020 Jan;48:100663. doi: 10.1016/j.drup.2019.100663. Epub 2019 Nov 11. Drug Resist Updat. 2020. PMID: 31785545 Review.

10

Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia.

Gupta P, Zhang GN, Barbuti AM, Zhang X, Karadkhelkar N, Zhou J, Ding K, Pan J, Yoganathan S, Yang DH, Chen ZS. Gupta P, et al. Among authors: chen zs. Cancer Lett. 2020 Mar 1;472:132-141. doi: 10.1016/j.canlet.2019.11.040. Epub 2019 Dec 11. Cancer Lett. 2020. PMID: 31837444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

883 results

Search Page

Filters